Understanding and Improving Dysphagia after Mechanical Ventilation
了解和改善机械通气后吞咽困难
基本信息
- 批准号:8617042
- 负责人:
- 金额:$ 21.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-05-01 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:Abnormal coordinationAcuteAcute respiratory failureAddressAffectAgeAmericanAnimal ModelArticular Range of MotionAspiration PneumoniaBarium swallowBreathingCervicalCessation of lifeChronicClinicalClinical Practice PatternsClinical ResearchClinical TrialsControl GroupsDataDeglutitionDeglutition DisordersEarly InterventionElderlyEnrollmentEsthesiaEvaluationExerciseFemaleFoundationsFrequenciesFunctional disorderFutureGoalsGrantHealthcareHospitalsHourImpairmentIntensive Care UnitsInterventionIntratracheal IntubationIntubationInvestigationIowaKnowledgeLaryngeal InjuryLaryngoscopyLarynxLeadLength of StayMassageMechanical ventilationMechanicsMediatingMentored Patient-Oriented Research Career Development AwardMentorsMorbidity - disease rateMotorMuscle WeaknessNatureOralOropharyngealOutcomePatientsPatternPenetrationPerformancePharyngeal structurePhasePhase I Clinical TrialsPhysical RehabilitationPhysical therapy exercisesPhysiologicalPhysiologyPrincipal InvestigatorRandomized Controlled TrialsRecruitment ActivityRehabilitation therapyResearchResearch MethodologyRiskRisk FactorsSamplingSedation procedureSensorySeveritiesSolidStrokeTimeTongueTracheostomy procedureTrainingUnited States National Institutes of Healthclinical careexperienceimprovedinstrumentkinematicslung injurymedical complicationmulti-component interventionmuscle formmuscle strengthnovelpatient oriented researchpatient populationpreventpublic health relevancesexstandardize measuresuccess
项目摘要
DESCRIPTION (provided by applicant): Annually, nearly 1 million Americans experience acute respiratory failure (ARF) requiring mechanical ventilation in intensive care units (ICU). Existing evidence demonstrates a strong association between oral endotracheal intubation and swallowing impairment (i.e., dysphagia) leading to aspiration, mediated by a combination of factors such as laryngeal injury, oropharyngeal muscle weakness, reduced laryngeal sensation, and breathing-swallowing dyscoordination. Understanding these issues is central to preventing and treating dysphagia in this patient population. After extubation, dysphagia affects up to 83% of patients and predisposes them to a 6-fold increased risk of aspiration pneumonia and a 3-fold increased risk of death compared with stroke patients. Without intervention, considerable muscle weakness and physical impairment occurs during ARF in the ICU, but recent trials demonstrate that less sedation combined with early physical rehabilitation during mechanical ventilation improve these impairments. Similarly, an early intervention for dysphagia during endotracheal intubation may improve patient outcomes. The overall goals of this study are to evaluate ARF patients from the time they are orally intubated in the ICU to: 1) investigate tongue weakness and other pathophysiological aspects of dysphagia, and 2) evaluate, in a Phase I clinical trial, a novel, multimodal, sensorimotor intervention conducted during intubation to reduce dysphagia after extubation. This K23 award also aims to provide the Principal Investigator with the background necessary to become independent in patient-oriented research by: 1) training in advanced aspects of clinical research methods with a focus on clinical trials; and 2) providing a mentored research experience for conducting this Phase I clinical trial focused on improving patient outcomes. Patients who are expected to be intubated with mechanical ventilation for >96 hours will be consecutively enrolled shortly after intubation. Laryngeal function, tongue strength, swallowing pathophysiology, and breathing-swallowing coordination will be evaluated with valid and reliable standardized measures. While orally intubated, patients in the treatment group will receive a novel, early, sensorimotor intervention for 60-minutes daily, targeting improved swallowing physiology and kinematics to reduce aspiration and dysphagia. These daily sessions will continue until the completion of a modified barium swallow study conducted within 48 hours after extubation, and thereafter standard clinical care will resume. Patients in the control group will receive standard clinical care during
intubation and throughout their hospital stay. All subjects will be followed to hospital discharge to determine the pathophysiological and clinical impact of the proposed intervention. Knowledge from this study will provide important feasibility data and preliminary efficacy data for the novel
intervention and provide a critical foundation for understanding the physiological mechanisms of dysphagia and aspiration after intubation in ARF patients.
描述(由申请人提供):每年,近 100 万美国人经历急性呼吸衰竭(ARF),需要在重症监护室(ICU)接受机械通气。现有证据表明,经口气管插管与导致误吸的吞咽障碍(即吞咽困难)之间存在密切关联,吞咽障碍是由喉部损伤、口咽肌无力、喉部感觉减弱和呼吸吞咽协调障碍等综合因素介导的。了解这些问题对于预防和治疗该患者群体的吞咽困难至关重要。拔管后,高达 83% 的患者会出现吞咽困难,与中风患者相比,他们患吸入性肺炎的风险增加 6 倍,死亡风险增加 3 倍。如果不进行干预,在 ICU 的 ARF 期间会出现相当大的肌肉无力和身体损伤,但最近的试验表明,机械通气期间较少的镇静结合早期身体康复可以改善这些损伤。同样,对气管插管期间吞咽困难的早期干预可能会改善患者的预后。本研究的总体目标是从 ARF 患者在 ICU 经口插管时起对其进行评估,以:1)调查舌无力和吞咽困难的其他病理生理学方面,2)在 I 期临床试验中评估一种新型的、插管期间进行多模式感觉运动干预,以减少拔管后的吞咽困难。该 K23 奖项还旨在通过以下方式为首席研究员提供独立进行以患者为导向的研究所需的背景:1)以临床试验为重点的临床研究方法高级方面的培训; 2) 为开展专注于改善患者治疗效果的 I 期临床试验提供指导性研究经验。预计机械通气插管时间>96小时的患者将在插管后不久连续入组。将通过有效且可靠的标准化措施来评估喉功能、舌头力量、吞咽病理生理学和呼吸吞咽协调。在经口插管时,治疗组的患者将每天接受 60 分钟的新颖、早期感觉运动干预,旨在改善吞咽生理和运动学,以减少误吸和吞咽困难。这些每日治疗将持续进行,直到完成拔管后 48 小时内进行的改良吞钡研究,此后将恢复标准临床护理。对照组患者将在治疗期间接受标准临床护理
插管期间和整个住院期间。所有受试者出院后均将被跟踪以确定所提议的干预措施的病理生理学和临床影响。这项研究的知识将为新型药物提供重要的可行性数据和初步疗效数据
干预并为了解 ARF 患者插管后吞咽困难和误吸的生理机制提供重要基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Martin Bruce Brodsky其他文献
Martin Bruce Brodsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Martin Bruce Brodsky', 18)}}的其他基金
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU
ICU拔管后喉损伤的症状评估和筛查
- 批准号:
10418749 - 财政年份:2018
- 资助金额:
$ 21.08万 - 项目类别:
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU
ICU拔管后喉部损伤的症状评估和筛查
- 批准号:
10207777 - 财政年份:2018
- 资助金额:
$ 21.08万 - 项目类别:
Symptoms Assessment and Screening for Laryngeal Injury Post-extubation in ICU
ICU拔管后喉损伤的症状评估和筛查
- 批准号:
9792391 - 财政年份:2018
- 资助金额:
$ 21.08万 - 项目类别:
Understanding and Improving Dysphagia after Mechanical Ventilation
了解和改善机械通气后吞咽困难
- 批准号:
9259958 - 财政年份:2014
- 资助金额:
$ 21.08万 - 项目类别:
Understanding and Improving Dysphagia after Mechanical Ventilation
了解和改善机械通气后吞咽困难
- 批准号:
8840926 - 财政年份:2014
- 资助金额:
$ 21.08万 - 项目类别:
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Molecular regulation of immunoproteasome assembly in inflammatory diseases
炎症性疾病中免疫蛋白酶体组装的分子调控
- 批准号:
10637422 - 财政年份:2023
- 资助金额:
$ 21.08万 - 项目类别:
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 21.08万 - 项目类别:
Early detection and identification of ventilator associated pneumonia
呼吸机相关性肺炎的早期发现和识别
- 批准号:
10663534 - 财政年份:2023
- 资助金额:
$ 21.08万 - 项目类别:
Natural model for evaluating within- and cross-species virus transmission
评估物种内和跨物种病毒传播的自然模型
- 批准号:
10735974 - 财政年份:2023
- 资助金额:
$ 21.08万 - 项目类别:
Novel Implementation of Microporous Annealed Particle HydroGel for Next-generation Posterior Pharyngeal Wall Augmentation
用于下一代咽后壁增强的微孔退火颗粒水凝胶的新实现
- 批准号:
10727361 - 财政年份:2023
- 资助金额:
$ 21.08万 - 项目类别: